Data di Pubblicazione:
2004
Citazione:
Leukotriene modifiers in asthma management / V. Capra, G.E. Rovati. - In: IDRUGS. - ISSN 1369-7056. - 7:7(2004), pp. 659-666.
Abstract:
The prevalence of asthma is increasing, especially among children. Despite the attention focused on the acute phase of asthma, asthmatic airways demonstrate increased inflammatory cell infiltration and irreversible structural alterations (remodeling). Thus, therapy must transcend the control of symptoms and focus on the prevention of chronic inflammation, which progressively evolves toward airway remodeling. Leukotrienes have been demonstrated to play a causative role both in the early bronchoconstriction noted in asthmatics and in the late chronic inflammatory component, and drugs that can inhibit the actions or synthesis of leukotrienes (leukotriene modifiers) are now available by prescription.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
cysteinyl-leukotrienes ; cysteinyl-leukotriene antagonists ; asthma
Elenco autori:
V. Capra, G.E. Rovati
Link alla scheda completa: